%0 Journal Article
%T Efficacy and Safety of Olopatadine/Mometasone Combination Nasal Spray in Patients With Seasonal Allergic Rhinitis
%A Andrew J. Pedinoff
%A Aurora Breazna
%A Cynthia F. Caracta
%A Frank C. Hampel
%A Robert L. Jacobs
%A Sudeesh K. Tantry
%J Journal of Allergy and Clinical Immunology
%D 2018
%R 10.1016/j.jaci.2017.12.550
%X Combining an intranasal antihistamine with an intranasal corticosteroid for the treatment
of allergic rhinitis (AR) may provide improved symptom relief over monotherapy treatment.
GSP301 nasal spray is a fixed-dose combination of the antihistamine olopatadine hydrochloride
and the corticosteroid mometasone furoate. The efficacy and safety of GSP301 were
evaluated in a large, phase 3 seasonal AR (SAR) study.
%U https://www.jacionline.org/article/S0091-6749(17)32450-8/abstract